5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.85▲ | 0.85▲ | 0.85▲ | 0.81▲ | 0.79▲ |
MA10 | 0.85▲ | 0.86▲ | 0.85▲ | 0.79▲ | 0.83▲ |
MA20 | 0.85▲ | 0.82▲ | 0.80▲ | 0.79▲ | 0.93▼ |
MA50 | 0.79▲ | 0.78▲ | 0.78▲ | 0.84▲ | 0.98▼ |
MA100 | 0.79▲ | 0.79▲ | 0.79▲ | 0.97▼ | 1.64▼ |
MA200 | 0.79▲ | 0.83▲ | 0.86▲ | 1.03▼ | 5.88▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | 0.000▲ | 0.005▲ | 0.014▲ | -0.010▼ |
RSI | 57.918▲ | 58.691▲ | 59.813▲ | 57.800▲ | 44.475▼ |
STOCH | 28.572 | 38.083 | 46.051 | 43.214 | 19.213▼ |
WILL %R | -62.839 | -43.774 | -30.287 | -37.161 | -69.562 |
CCI | 20.302 | 56.082 | 69.557 | 125.966▲ | -36.893 |
Friday, August 15, 2025 01:58 PM
Predictive Oncology faces financial challenges, a $2M Q2 loss, and potential Nasdaq delisting while exploring solutions amid legal troubles.
|
Thursday, August 14, 2025 05:24 AM
Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive ...
|
Monday, July 21, 2025 02:24 AM
Predictive Oncology (POAI) has announced a plan to offer 1.92 million shares of its common stock for sale by its existing holders.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 0.87 | 0.87 | 0.8188 | 0.8561 | 171,771 |
14/08/25 | 0.91 | 0.915 | 0.826 | 0.87 | 186,200 |
13/08/25 | 0.74 | 0.9425 | 0.74 | 0.87 | 793,849 |
12/08/25 | 0.72 | 0.789 | 0.72 | 0.74 | 326,900 |
11/08/25 | 0.76 | 0.7789 | 0.71 | 0.7256 | 178,735 |
08/08/25 | 0.791 | 0.791 | 0.75 | 0.76 | 192,100 |
07/08/25 | 0.80 | 0.80 | 0.752 | 0.753 | 100,100 |
06/08/25 | 0.77 | 0.815 | 0.77 | 0.815 | 141,200 |
05/08/25 | 0.78 | 0.79 | 0.7529 | 0.7699 | 47,694 |
04/08/25 | 0.77 | 0.81 | 0.763 | 0.774 | 132,400 |
|
|
||||
|
|
||||
|
|